Profile data is unavailable for this security.
About the company
Immunovia AB (publ) is a Sweden-based diagnostic company that is developing and commercializing blood tests for the early detection of cancer and autoimmune diseases based on Immunovia’s test platform called IMMray. Tests are based on antibody biomarker microarray analysis using machine-learning and bioinformatics to single-out a set of relevant biomarkers that indicate a certain disease. Thus, forming a disease biomarker signature. Immunovia Dx Laboratories locations in USA and Sweden provides laboratory testing services in two accredited reference laboratories.
- Revenue in SEK (TTM)1.58m
- Net income in SEK-309.44m
- Incorporated2007
- Employees11.00
- LocationImmunovia AB (publ)Medicon Village, Scheelevagen 8LUND 223 63SwedenSWE
- Phone+46 462756000
- Websitehttps://immunovia.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alzinova AB | 270.00k | -16.48m | 77.93m | -- | -- | 0.6845 | -- | 288.63 | -0.4149 | -0.4149 | 0.0067 | 2.56 | 0.0023 | -- | 0.3671 | -- | -14.04 | -10.77 | -14.91 | -11.27 | 7,360.55 | -- | -6,103.69 | -18,447.90 | -- | -- | 0.007 | -- | -- | -- | -25.92 | -- | 15.81 | -- |
| Bioextrax AB publ | 2.06m | -21.51m | 80.97m | -- | -- | 3.37 | -- | 39.36 | -0.8026 | -0.8026 | 0.0769 | 0.6968 | 0.0681 | -- | 124.67 | -- | -71.18 | -86.39 | -82.24 | -110.84 | 34.95 | -- | -1,045.55 | -2,119.90 | -- | -- | -- | -- | 420.51 | 24.40 | -15.21 | -- | 56.86 | -- |
| NextCell Pharma AB | 12.22m | -40.69m | 82.51m | -- | -- | 1.25 | -- | 6.75 | -1.18 | -1.18 | 0.3555 | 1.92 | 0.124 | 14.66 | 6.80 | -- | -41.28 | -34.92 | -45.63 | -37.06 | 6.61 | -68.21 | -332.90 | -538.60 | 4.97 | -- | 0.00 | -- | 80.96 | 72.85 | -15.21 | -- | -- | -- |
| AroCell AB (publ) | 43.04m | -59.30m | 84.08m | -- | -- | 0.5138 | -- | 1.95 | -0.2574 | -0.2574 | 0.1868 | 0.7104 | 0.2095 | 6.68 | 6.52 | -- | -28.86 | -29.25 | -30.70 | -31.37 | -4.38 | -9.85 | -137.78 | -231.19 | 5.25 | -- | 0.00 | -- | 16.37 | 122.92 | -0.5494 | -- | -- | -- |
| Odi Pharma AB (publ) | 818.38k | -3.97m | 86.75m | -- | -- | 42.61 | -- | 106.01 | -0.2608 | -0.2608 | 0.0538 | 0.1338 | 0.1084 | 1.22 | 6.98 | -- | -52.58 | -- | -95.24 | -- | -53.07 | -- | -484.96 | -- | 1.32 | -14.10 | 0.00 | -- | -55.44 | -- | 4.67 | -- | -- | -- |
| Dextech Medical AB | 0.00 | -4.57m | 91.69m | 1.00 | -- | 2.84 | -- | -- | -0.2473 | -0.2473 | 0.00 | 1.75 | 0.00 | -- | -- | -- | -13.04 | -28.96 | -13.21 | -29.94 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 12.89 | -- | 0.412 | -- |
| Sprint Bioscience AB | 50.49m | -441.00k | 94.96m | 28.00 | -- | 3.42 | 13,565.05 | 1.88 | -0.0064 | -0.0064 | 0.7232 | 0.3978 | 1.01 | -- | 7.58 | 1,803,036.00 | -0.8838 | -71.22 | -1.58 | -113.71 | 82.77 | 62.75 | -0.8735 | -110.22 | -- | -- | 0.00 | -- | 60,725.30 | 22.99 | 99.27 | -- | -26.02 | -- |
| Immunovia AB (publ) | 1.58m | -309.44m | 95.10m | 11.00 | -- | 1.42 | -- | 60.38 | -8.27 | -8.27 | 0.0412 | 1.48 | 0.0079 | 74.81 | 7.89 | 143,181.80 | -155.00 | -41.33 | -179.24 | -44.24 | -4,687.68 | -7,553.76 | -19,646.92 | -20,879.26 | 2.69 | -22.84 | 0.1329 | -- | 37.55 | 36.48 | -84.09 | -- | -50.93 | -- |
| Biosergen AB | 0.00 | -27.04m | 96.86m | 3.00 | -- | 8.36 | -- | -- | -0.4007 | -0.4007 | 0.00 | 0.0418 | 0.00 | -- | -- | 0.00 | -131.31 | -- | -217.09 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 32.25 | -- | -- | -- |
| Annexin Pharmaceuticals AB (publ) | 0.00 | -46.41m | 97.04m | 4.00 | -- | 15.29 | -- | -- | -0.1887 | -0.1887 | 0.00 | 0.0183 | 0.00 | -- | -- | 0.00 | -256.08 | -125.42 | -351.79 | -151.33 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -8.17 | -- | -- | -- |
| Toleranzia AB | 0.00 | -7.46m | 98.54m | -- | -- | 0.6419 | -- | -- | -0.0597 | -0.0597 | 0.00 | 0.779 | 0.00 | -- | -- | -- | -5.21 | -7.45 | -5.43 | -7.78 | -- | -- | -- | -- | -- | -- | 0.0055 | -- | -- | -- | 11.79 | -- | 63.90 | -- |
| Ziccum AB | 3.75m | -21.41m | 100.32m | 8.00 | -- | 10.56 | -- | 26.77 | -1.54 | -1.54 | 0.2701 | 0.6191 | 0.1553 | -- | 2.01 | 468,375.00 | -88.74 | -68.51 | -109.73 | -76.47 | -- | -- | -571.44 | -2,598.03 | -- | -- | 0.0908 | -- | -- | 75.20 | 25.62 | -- | -13.45 | -- |
| Wntresearch AB | 0.00 | -32.47m | 103.49m | 2.00 | -- | 0.6516 | -- | -- | -0.1108 | -0.1108 | 0.00 | 0.1834 | 0.00 | -- | -- | -- | -134.87 | -100.71 | -166.68 | -123.59 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -5.65 | -- | -- | -- |
| Bio-Works Technologies AB | 43.90m | -56.82m | 107.58m | 38.00 | -- | 2.44 | -- | 2.45 | -1.58 | -1.58 | 1.22 | 1.13 | 0.571 | 1.82 | 5.83 | 1,155,158.00 | -73.91 | -49.14 | -101.72 | -57.90 | 61.10 | 69.88 | -129.44 | -168.30 | 2.79 | -- | 0.00 | -- | 6.23 | 46.24 | -26.41 | -- | 1.95 | -- |
| Isofol Medical AB (publ) | 721.00k | -37.07m | 111.77m | 3.00 | -- | 0.9204 | -- | 155.02 | -0.233 | -0.233 | 0.0045 | 0.7518 | 0.0041 | -- | 0.0728 | 240,333.30 | -21.15 | -66.73 | -26.32 | -88.27 | -4,773.37 | -- | -5,141.61 | -1,023.62 | -- | -- | 0.00 | -- | -94.37 | -- | 76.80 | -- | -- | -- |
| Opticept Technologies AB | 9.15m | -80.36m | 112.27m | 29.00 | -- | 0.3052 | -- | 12.28 | -2.51 | -2.51 | 0.2844 | 8.72 | 0.0213 | -0.0638 | 2.37 | 315,344.80 | -18.69 | -41.76 | -21.18 | -46.20 | 125.88 | 62.65 | -879.64 | -882.41 | 0.6216 | -14.16 | 0.0566 | -- | -12.90 | 49.17 | 19.80 | -- | 45.22 | -- |
Data as of Apr 25 2024. Currency figures normalised to Immunovia AB (publ)'s reporting currency: Swedish Krona SEK
2.61%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| SEB Investment Management ABas of 28 Mar 2024 | 307.81k | 0.68% |
| Coeli Asset Management ABas of 30 Jun 2021 | 307.37k | 0.68% |
| Handelsbanken Fonder ABas of 31 Mar 2024 | 304.61k | 0.67% |
| Banor Capital Ltd.as of 29 Feb 2024 | 200.00k | 0.44% |
| Storebrand Asset Management ASas of 31 Jan 2024 | 46.50k | 0.10% |
| Skandia Investment Management ABas of 29 Feb 2024 | 12.00k | 0.03% |
| Case Kapitalf�rvaltning ABas of 30 Nov 2022 | 2.26k | 0.01% |
| SSgA Funds Management, Inc.as of 04 Apr 2024 | 350.00 | 0.00% |
| FCG Fonder ABas of 31 Oct 2023 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2022 - 19 Apr 2024Source: FactSet Research Systems Inc.
